This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Sep. 13, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel



Scientists develop genetic test to predict autism
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Australian scientists have developed a genetic test to predict autism spectrum disorder in children, which could provide a long-sought way for early detection and intervention, according to a new study. About 1 in 150 children has autism, with symptoms ranging from social awkwardness and narrow interests to severe communication and intellectual disabilities, said researchers led by the University of Melbourne. More

'Bubble babies' get new immune system through novel gene therapy
Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For small children with severe combined immunodeficiency — more famously known as "bubble boy syndrome" — disease and infection are a constant source of worry due to a weakened, or almost non-existent immune system. If left untreated, the condition is fatal in just one to two years. Researchers have spent 11 years creating and testing a novel gene therapy, which is capable of restoring immune systems in children with ADA-deficient SCID. More

Now Hiring! Disability Examination Providers

The VA Locum Tenens Program seeks physicians and psychologists to perform disability examinations for general medicine and mental health conditions. Physicians will provide compensation and pension examinations for Veterans who file for disability claims. This position requires extensive travel around the country. Compensation package includes salary and full travel. Send your CV to or contact us at 1-866-664-1030.

Stealth techniques being developed to delay cancer tumor growth
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The way in which cancer can spread silently and unnoticed in the body — with symptoms in some cases remaining latent for months, years, or even decades — is often noted as its most deadly feature. Researchers around the world have been devising ever more sophisticated strategies to fight cancer — including "stealth" techniques designed to outwit the body's immune system so as to deliver therapeutic drugs, genes, proteins and viruses to carefully targeted disease sites. More

 Biotech/Diagnostics/Personalized Medicine

Study shows importance of gene-gene interactions
Health Canal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Gaining more insight into predicting how genes affect physical or behavioral traits by charting the genotype-phenotype map holds promise to speed discoveries in personalized medicine. But figuring out exactly how genes interact has left parts of the map invisible. More


Your patient's blood doesn't tell you that they will get tired walking the dog. Or that they've had heartburn for the past 2 weeks. But it can tell you whether or not obstructive CAD is what's causing their symptoms. You may not need to go deeper than the blood to know what's happening. MORE

Even with personalized assessments, many underestimate disease risks
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
People with a family history of certain diseases, including heart disease and diabetes, often underestimate their risk for developing them, even after completing a risk assessment and receiving personalized prevention messages, finds a new study in the American Journal of Preventive Medicine. More

Pharmaceutical products that make a difference
Forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems and are always exploring new product opportunities. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

 Regenerative Medicine

Deaf gerbils hear again with human stem cells
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have restored hearing to deaf gerbils using human embryonic stem cells in an advance that could eventually help people with an intractable form of deafness caused by nerve damage. The procedure needs further animal research to assess safety and long-term effectiveness but researchers said the experiment was an important proof of concept, marking a further advance in the growing field of regenerative medicine. More

 Emerging Medical Technologies

FDA clear Mayo technology-powered mobile health, remote monitoring
MedCity News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Preventice, a Minneapolis mobile health and remote monitoring company announced that its BodyGuardian Remote Monitoring System has been cleared by the Food and Drug Administration. The miniature device, worn underneath the clothes next to the chest is able to monitor heart rate, ECG, respiratory rate and physical activity. More

Preliminary findings released for robotic exoskeleton in spinal injury
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso. The research focuses on new ways to improve function and restore mobility for people with disabilities and reduce their long-term risks for complications. More

 Managed Healthcare News

Healthcare reform law to usher in new age of consumerism
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Patient Protection and Affordable Care Act is changing the way insurers do business. A few years from now, you may see your health plan in a different light. You might even decide you like it — even if it's not that much more affordable. But it's not all good news: Future employers are also expected to shift more costs to employees, and consumers will generally take on more of their healthcare expenses. More

Medicare pilot program shows cost savings for treating dual eligibles
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers released a deeper look at the Physician Group Practice Demonstration, one of the federal government's first pay-for-performance experiments to improve healthcare and reduce costs for the Medicare population. They found that it created significant savings — especially for dual eligibles, which is the population who receives health coverage through both Medicare and Medicaid and who are often the health system's sickest and costliest patients. More

 FDA: New Treatments and Technology

FDA unveils device that detects counterfeit drugs
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration has a new cutting-edge tool in its counterfeit drug detection toolbox. The agency unveiled the Counterfeit Detection Device #3 or CD3, a hand-held device developed by FDA scientists that can be used in the field to detect counterfeit products and packaging. More

Studies: Failed Alzheimer's drug showed signs of working
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
New data on Pfizer and Johnson & Johnson's Alzheimer's drug, bapineuzumab, show the treatment reduced underlying markers of the disease in some patients, suggesting the failed medication might work at an earlier stage. More

"All forms of severe combined immunodeficiency are inherited, with as many as half of all cases passed on by the patient's mother, according to the National Institutes of Health."

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Sept. 6, 2012
Aug. 30, 2012
Aug. 23, 2012
Aug. 16, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063